Doses (mSv) to 9-Month-Pregnant Models from 3.7-MBq 1-Day Protocol
| Organ | Reference model | MSKCC model | MSKCC childbearing model |
|---|---|---|---|
| Adrenals | 7.19E−03 | 6.50E−03 | 6.76E−03 |
| Brain | 5.39E−04 | 4.87E−04 | 5.06E−04 |
| Injected breast | 2.97E+00 | 1.10E+00 | 1.49E+00 |
| Gallbladder wall | 5.84E−03 | 5.30E−03 | 5.49E−03 |
| LLI wall | 1.18E−03 | 1.07E−03 | 1.11E−03 |
| Small intestine | 6.99E−03 | 6.34E−03 | 6.57E−03 |
| Stomach wall | 1.18E−02 | 1.07E−02 | 1.11E−02 |
| ULI wall | 6.73E−03 | 6.09E−03 | 6.32E−03 |
| Heart wall | 4.28E−02 | 3.87E−02 | 4.02E−02 |
| Kidneys | 3.05E−03 | 2.77E−03 | 2.87E−03 |
| Liver | 1.24E−02 | 1.12E−02 | 1.16E−02 |
| Lungs | 3.02E−02 | 2.74E−02 | 2.84E−02 |
| Muscle | 6.64E−03 | 6.00E−03 | 6.23E−03 |
| Ovaries | 7.25E−04 | 6.55E−04 | 6.77E−04 |
| Pancreas | 8.90E−03 | 8.06E−03 | 8.36E−03 |
| Red marrow | 7.03E−03 | 6.34E−03 | 6.57E−03 |
| Osteogenic cells | 1.15E−02 | 1.04E−02 | 1.08E−02 |
| Skin | 1.10E−02 | 9.99E−03 | 1.04E−02 |
| Spleen | 6.17E−03 | 5.60E−03 | 5.79E−03 |
| Thymus | 3.27E−02 | 2.96E−02 | 3.07E−02 |
| Thyroid | 4.69E−03 | 4.27E−03 | 4.42E−03 |
| Bladder wall | 4.62E−04 | 4.17E−04 | 4.33E−04 |
| Uterus | 3.19E−03 | 2.89E−03 | 3.00E−03 |
| Fetus | 2.73E−03 | 2.48E−03 | 2.57E−03 |
| Placenta | 5.85E−03 | 5.32E−03 | 5.51E−03 |
| Total body | 1.49E−02 | 1.34E−02 | 1.39E−02 |
| Effective dose | 9.19E−02 | 3.72E−02 | 4.90E−02 |